Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry
NCT ID: NCT03231644
Last Updated: 2025-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2016-10-31
2028-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Have you enrolled in the FD/MAS Patient Registry yet? Are you up-to-date on your surveys? Take a trip to www.fdmasregistry.org today to learn more about the project, enroll, complete your surveys, or make sure you aren't due to provide more info!
The FD/MAS Patient Registry: Your story powers research.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome
NCT00001727
Artificial Intelligence Patient App for RDEB SCCs
NCT05843994
Defining the Basis of Fibromuscular Dysplasia (FMD)
NCT01967511
Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
NCT03329274
Duke Scleroderma Clinic Patient Registry
NCT02851875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The surveys were created in collaboration with patients, parents, clinicians and researchers, so that the data can be used to answer some of the most important questions about FD/MAS, including:
the way the disease develops over time (its "natural history"), the patient experience of the disease, and its impact on quality of life, how and when diagnoses are made, the scope of treatments in use, what surgical techniques work best, and for whom, what other medical interventions work best, and for whom, what social services and therapies are useful, the costs of care to patients and their families, issues that concern patients (such as the impact of pregnancy on FD, or children feeling different and facing stigma), and which research questions and support programs you think are important to fund.
Participation is free and convenient for people with FD/MAS and their legal guardians. You can join today at www.fdmasregistry.org.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FD/MAS Patients
Patients with fibrous dysplasia and/or McCune-Albright syndrome and related disorders.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical diagnosis of McCune-Albright syndrome
* clinical diagnosis of Mazabraud's syndrome
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tovah Burstein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tovah Burstein
Community Engagement Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tovah Burstein
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00018980.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.